Next Article in Journal
A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer
Next Article in Special Issue
Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
Previous Article in Journal
Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up
Previous Article in Special Issue
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Article

Article Versions Notes

Cancers 2021, 13(8), 1762; https://doi.org/10.3390/cancers13081762
Action Date Notes Link
article pdf uploaded. 7 April 2021 12:32 CEST Updated version of record https://www.mdpi.com/2072-6694/13/8/1762/pdf
article supplementary file uploaded. 7 April 2021 12:32 CEST - https://www.mdpi.com/2072-6694/13/8/1762#supplementary
article xml file uploaded 8 April 2021 04:15 CEST Update https://www.mdpi.com/2072-6694/13/8/1762/xml
article xml uploaded. 8 April 2021 04:15 CEST Update https://www.mdpi.com/2072-6694/13/8/1762/xml
article pdf uploaded. 8 April 2021 04:15 CEST Updated version of record https://www.mdpi.com/2072-6694/13/8/1762/pdf
article html file updated 8 April 2021 04:16 CEST Update https://www.mdpi.com/2072-6694/13/8/1762/html
article html file updated 11 April 2021 12:42 CEST Update https://www.mdpi.com/2072-6694/13/8/1762/html
Back to TopTop